Analyst Research Report Snapshot

Title:

BAVARIAN NORDIC - ADR UPDATE: EXPANDING THE BIODEFENSE

Price:

$10.00

Provider:

Edison Investment Research

Date:

26 Feb 2014

Pages:

6

Type:

AcrobatPDF

Companies referenced:

BAVA.CO

Available for Immediate Download
Summary:

Bavarian Nordic has been awarded a new US government biodefense contract for the development of infectious disease vaccines based on its MVA-BN platform. The $0.5m contract will fund the design, development and testing of vaccines against two bacterial pathogens, Burkholderia pseudomallei and Burkholderia mallei. Prostvac remains the key value driver; however this contract win highlights Bavarian Nordic’s expertise in developing infectious disease vaccines and the strength of its MVA-BN platform. It also broadens the R&D pipeline and brings the total value of US government biodefense contracts awarded to date to over $1.02bn.

Why buy analyst research?

  • Institutional quality research
  • Available for Immediate Download
  • Detailed company or industry insight
  • Print or save
  • 24 hour customer support
Return to previous page without adding this item to your cart.
Email Customer Support.

About Analyst Research

Analyst research reports are available for immediate download after purchase. You will have unlimited access to the report for 24 hours after purchase, to download, print or save it as many times as you wish. Analyst Research provided by Reuters does not constitute investment advice, and is not endorsed by Reuters Research. This information is protected by copyright and intellectual property laws. More information on Analyst Research.